Characterization of Drug-Resistant Influenza A(H7N9) Variants Isolated From an Oseltamivir-Treated Patient in Taiwan
Supporting Files
-
1 15 2015
-
Available in CDC Stacks on 2020-01-06T00:00:00Z
File Language:
English
Details
-
Journal Article:J Infect Dis
-
Personal Author:Marjuki, Henju ; Mishin, Vasiliy P. ; Chesnokov, Anton P. ; Jones, Joyce ; De La Cruz, Juan A. ; Sleeman, Katrina ; Tamura, Daisuke ; Nguyen, Ha T. ; Wu, Ho-Sheng ; Chang, Feng-Yee ; Liu, Ming-Tsan ; Fry, Alicia M. ; Cox, Nancy J. ; Villanueva, Julie M. ; Davis, Charles T. ; Gubareva, Larisa V.
-
Description:Background. ; Patients contracting influenza A(H7N9) infection often developed severe disease causing respiratory failure. Neuraminidase (NA) inhibitors (NAIs) are the primary option for treatment, but information on drugresistance markers for influenza A(H7N9) is limited. ; Methods. ; Four NA variants of A/Taiwan/1/2013(H7N9) virus containing a single substitution (NA-E119V, NA-I222K, NA-I222R, or NA-R292K) recovered from an oseltamivir-treated patient were tested for NAI susceptibility in vitro; their replicative fitness was evaluated in cell culture, mice, and ferrets. ; Results. ; NA-R292K led to highly reduced inhibition by oseltamivir and peramivir, while NA-E119V, NA-I222K, and NA-I222R caused reduced inhibition by oseltamivir. Mice infected with any virus showed severe clinical signs with high mortality rates. NA-I222K virus was the most virulent in mice, whereas virus lacking NA change (NA-WT) and NA-R292K virus seemed the least virulent. Sequence analysis suggests that PB2-S714N increased virulence of NA-I222K virus in mice; NS1-K126R, alone or in combination with PB2-V227M, produced contrasting effects in NA-WT and NA-R292K viruses. In ferrets, all viruses replicated to high titers in the upper respiratory tract but produced only mild illness. NA-R292K virus, showed reduced replicative fitness in this animal model. ; Conclusions. ; Our data highlight challenges in assessment of the replicative fitness of H7N9 NA variants that emerged in NAI-treated patients.
-
Subjects:
- Animals
- Antiviral Agents
- Disease Models, Animal
- Drug Resistance, Viral
- Ferrets
- Humans
- Influenza A Virus, H7N9 Subtype
- Influenza, Human
- Mice, Inbred BALB C
- Microbial Sensitivity Tests
- Mutant Proteins
- Mutation, Missense
- Neuraminidase
- Orthomyxoviridae Infections
- Oseltamivir
- Viral Proteins
- Virus Cultivation
- Virus Replication
-
Keywords:
-
Source:J Infect Dis. 211(2):249-257
-
DOI:
-
Pubmed ID:25124927
-
Pubmed Central ID:PMC6943751
-
Document Type:
-
Funding:
-
Genre:
-
Volume:211
-
Issue:2
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:faded880e1de116a6494c6672dde5df9d655fb27a0d49881b12f93738eac73c9a3fda61c4e5c33edeeb5c5fa126311db077cd8bbac915eca1892687f1e369e0d
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access